237 related articles for article (PubMed ID: 26044127)
1. Urinary bladder urothelial carcinoma with concurrent plasmacytoid and micropapillary differentiations: A report of two cases with an emphasis on serum carbohydrate antigen 19-9.
Makise N; Morikawa T; Takeshima Y; Fujimura T; Homma Y; Fukayama M
Pathol Int; 2015 Sep; 65(9):495-500. PubMed ID: 26044127
[TBL] [Abstract][Full Text] [Related]
2. Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.
Tajima S; Koda K
Int J Clin Exp Pathol; 2015; 8(3):3288-93. PubMed ID: 26045854
[TBL] [Abstract][Full Text] [Related]
3. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
Cox R; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid urothelial carcinoma of the bladder.
Kohno T; Kitamura M; Akai H; Takaha M; Kawahara K; Oka T
Int J Urol; 2006 Apr; 13(4):485-6. PubMed ID: 16734884
[TBL] [Abstract][Full Text] [Related]
5. Micropapillary urothelial carcinoma: an aggressive variant of urothelial carcinoma.
Loghin A; Chibelean C; Orsolya M; Nechifor-Boilă A; Nechifor-Boilă A; Borda A
Rom J Morphol Embryol; 2014; 55(3):939-45. PubMed ID: 25329124
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma.
Shah TS; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff DJ; Chen G; Warrick JI
Hum Pathol; 2017 Mar; 61():90-96. PubMed ID: 27818288
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.
Keck B; Wach S; Stoehr R; Kunath F; Bertz S; Lehmann J; Stöckle M; Taubert H; Wullich B; Hartmann A
BMC Cancer; 2013 Feb; 13():71. PubMed ID: 23394492
[TBL] [Abstract][Full Text] [Related]
8. Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder.
Keck B; Wach S; Kunath F; Bertz S; Taubert H; Lehmann J; Stöckle M; Wullich B; Hartmann A
Ann Surg Oncol; 2013 Jul; 20(7):2440-5. PubMed ID: 23108554
[TBL] [Abstract][Full Text] [Related]
9. Micropapillary urothelial carcinoma: clinico-pathologic review.
Perepletchikov AM; Parwani AV
Pathol Res Pract; 2009; 205(12):807-10. PubMed ID: 19767154
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid variant urothelial bladder cancer: is it time to update the treatment paradigm?
Kaimakliotis HZ; Monn MF; Cary KC; Pedrosa JA; Rice K; Masterson TA; Gardner TA; Hahn NM; Foster RS; Bihrle R; Cheng L; Koch MO
Urol Oncol; 2014 Aug; 32(6):833-8. PubMed ID: 24954925
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
[TBL] [Abstract][Full Text] [Related]
12. Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma.
Straccia P; Martini M; Sacco E; Bassi PF; Pierconti F
Diagn Cytopathol; 2020 Feb; 48(2):111-117. PubMed ID: 31650714
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical Differentiation of Plasmacytoid Urothelial Carcinoma From Secondary Carcinoma Involvement of the Bladder.
Borhan WM; Cimino-Mathews AM; Montgomery EA; Epstein JI
Am J Surg Pathol; 2017 Nov; 41(11):1570-1575. PubMed ID: 28786878
[TBL] [Abstract][Full Text] [Related]
14. [A case of micropapillary bladder carcinoma].
Matsumura E; Ashikari A; Tasaki S; Kato S; Ashimine S; Machida N; Toyama H; Oshiro Y; Saito S
Hinyokika Kiyo; 2012 Jun; 58(6):279-82. PubMed ID: 22874506
[TBL] [Abstract][Full Text] [Related]
15. Sarcomatoid variant of urothelial carcinoma of the urinary bladder.
Bansal A; Kumar N; Sharma SC
J Cancer Res Ther; 2013; 9(4):571-3. PubMed ID: 24518698
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
17. Urothelial Carcinoma In Situ of the Bladder With Glandular Differentiation: Report of 92 Cases.
Yang Z; Epstein JI
Am J Surg Pathol; 2018 Jul; 42(7):971-976. PubMed ID: 29683821
[TBL] [Abstract][Full Text] [Related]
18. Implications of micropapillary urothelial carcinoma variant on prognosis following radical cystectomy: A multi-institutional investigation.
Mitra AP; Fairey AS; Skinner EC; Boorjian SA; Frank I; Schoenberg MP; Bivalacqua TJ; Hyndman ME; Reese AC; Steinberg GD; Large MC; Hulsbergen-van de Kaa CA; Bruins HM; Daneshmand S
Urol Oncol; 2019 Jan; 37(1):48-56. PubMed ID: 30446450
[TBL] [Abstract][Full Text] [Related]
19. Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma.
Terada T
Int J Clin Exp Pathol; 2013; 6(6):1150-6. PubMed ID: 23696935
[TBL] [Abstract][Full Text] [Related]
20. Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
Philippou P; Kariotis I; Volanis D; Ploumides A; Delakas D
Urol Int; 2011; 86(3):370-2. PubMed ID: 21325783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
